|
|
|
Pharmaceutical Manufacturing and Packing Sourcer
|
The pharmaceutical industry has been moving away from the traditional research-driven business model to one that is motivated by the marketing of major branded products. Compelled by the need to create bestseller products and then defend their sales post-patent expiry, pharmaceutical companies are increasingly using the power of branding to capture the hearts and minds of the public.
Colours are often the central element of a product's branding, and reputation can be built on colour alone. By way of example, AstraZeneca's Losec was promoted as the 'purple pill' in advertisements, and the replacement for Losec - Nexium - is the same colour and is referred to as 'the new purple pill'. Also, in advertisements for Pfizer's Viagra, Bob Dole refers to the pill as his 'little blue friend'. So to what extent can companies protect the colours of their products and packaging as national trademarks in the UK, or alternatively as community trademarks (CTMs)?
This article will briefly discuss the advantages of registered Trademarks and the approach taken by the UK Trade Marks Registry and the Office of Harmonisation for the Internal Market (OHIM) (which grants CTMs) towards the registration of colours as trademarks. It will then discuss the recent European Court of Justice (ECJ) decision in Libertel Groep BV v Benelux-Merkenbureau (1), which will have an important impact on the way in which EU trademark offices will approach applications to register colour marks in the future and consequently on the way colours will be used in the pharmaceutical industry as source identifiers.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
Merck Launches ADC ExpressTM Services to Accelerate Pre-clinical Conjugation Candidate Selection
• Provides rapid production of antibody drug conjugates (ADCs) for best candidate selection
• Established platform technology to reliably scale target molecules
• Reduces time to clinic through comprehensive ADC services from pre-clinical to commercial from a single source
More info >> |
|
 |
White Papers |
 |
|
The Importance of Critical Temperatures in the Freeze Drying of Pharmaceutical Products
Biopharma Group
Every formulation has a critical temperature, below which it should be cooled for complete solidification and maintained below during primary drying in order to prevent processing defects. To design a freeze drying cycle on a rational basis such information should be identified.
More info >> |
|
 |
Industry Events |
 |
2020 Avoca Quality and Innovation Summit
3-4 June 2020, Amsterdam, The Netherlands
The 2020 Avoca Quality and Innovation Summit will take place 3-4 June
2020, in Amsterdam, The Netherlands.
More info >> |
|
|
